tiprankstipranks
Trending News
More News >
Seres Therapeutics (DE:1S90)
FRANKFURT:1S90

Seres Therapeutics (1S90) Revenue

Compare
1 Followers

Seres Therapeutics Revenue

Seres Therapeutics had a revenue of 438.00K in the quarter ending Dec 31, 2025, with 24.79%. This bring the company's revenue in the last twelve months to 789.00K, Decreased 124.79%. In the fiscal year ending Dec 31, 2025, Seres Therapeutics had annual revenue of 789.00K with Infinity% growth.
Revenue (ttm)
789.00K
Revenue Growth
P/S Ratio
95.39
Revenue/Employee
$7,660
Employees
103
Market Cap
$75.27M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
789.00K+∞%
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
-144.93M-100.00%
Dec 31, 2021
144.93M111.71M+336.33%
Dec 31, 2020
33.22M-1.29M-3.74%
Dec 31, 2019
34.51M6.24M+22.07%
Dec 31, 2018
28.27M-3.83M-11.94%
Dec 31, 2017
32.10M